HempStreet announced a partnership with MGC Pharmaceuticals Ltd. to revolutionize Global Phytomedicine Sector. The partnership will also accelerate HempStreet's upcoming venture - transdermal delivery technology for cannabinoids - to launch in the markets beyond Asia with the help of MGC Pharma's widespread distribution network in Australia, the UK, Brazil, and Ireland.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.405 AUD | -4.71% | -6.90% | -14.74% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.08% | 6.01B | |
-16.43% | 4.47B | |
-12.46% | 3.11B | |
-0.21% | 3.01B | |
-0.59% | 2.6B | |
+34.54% | 1.85B | |
+0.93% | 1.66B | |
-10.63% | 1.63B | |
-12.50% | 1.53B |
- Stock Market
- Equities
- RGT Stock
- MXC Stock
- News Argent BioPharma Limited
- HempStreet Announces a Partnership with MGC Pharmaceuticals Ltd